JPMorgan Starts Silk Road Medical (SILK) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
Go back to JPMorgan Starts Silk Road Medical (SILK) at Overweight
April 29, 2019 9:54 AM EDT
BofA/Merrill Lynch initiates coverage on Silk Road Medical (NASDAQ: SILK) with a Neutral rating.
For an analyst ratings summary and ratings history on Silk Road Medical click here. For more ratings news on Silk Road Medical click here.
Shares of Silk Road Medical closed at $40.01 yesterday.
...
More
April 29, 2019 5:26 AM EDT
(Updated - April 29, 2019 6:46 AM EDT)
(updated to add analyst comments)
BMO Capital analyst Joanne Wuensch initiates coverage on Silk Road Medical (NASDAQ: SILK) with a Outperform rating.
"Silk Roads ENROUTE TCAR system follows the classic transition from open to minimally invasive... More
April 29, 2019 2:49 AM EDT
Stifel analyst Rick Wise initiates coverage on Silk Road Medical (NASDAQ: SILK) with a Buy rating and a price target of $44.00.
The analyst comments "Based on highly compelling clinical data, we believe over the next few years TCAR is poised to become standard of... More
